Genmab — Juli 2020
-
FDA AdCom recommends GSK’s anti-BCMA drug for approval 12-0 despite searing in-house review — does it matter? https://endpts.com/fda-adcom-recommends-gsks-anti-bcma-drug-for-approval-12-0-despite-searing-in-house-review-does-it-matter/
-
Det plejer at virke.
-
The Novo N Haemophilia A gets extended; phase 2 goes to 120 weeks instead of 31 weeks. That is a lot more doses, or should i say revenue https://clinicaltrials.gov/ct2/history/NCT04204408?A=8&B=9&C=merged#StudyPageTop
-
US: 2.373
-
Jeg brugte en valutaomregner. Den sagde vist 6,59.
-
Jeg tjekkede udregningen da jeg så dit opslag. Dermed kunne jeg regne ud at det var 6,59. Må holde op med at google den slags.:-)
-
Daratumumab and high-risk cytognetics. https://www.proinvestor.com/?p=debat_1&postid=85151&thread=50&start=
-
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind